Intraoperative Radiation Therapy Market to Reach US$ 266.9 Million by 2035 Amid Rising Adoption of Precision Cancer Treatments

The global intraoperative radiation therapy (IORT) market was valued at US$ 121.7 million in 2024 and is projected to reach US$ 266.9 million by 2035, expanding at a CAGR of 7.4% from 2025 to 2035. Market growth is driven by the rising prevalence of cancer, increasing adoption of targeted radiation therapies, and advancements in minimally invasive oncology treatment technologies.

As healthcare providers increasingly focus on improving treatment accuracy, minimizing radiation exposure to healthy tissues, and enhancing patient outcomes, intraoperative radiation therapy has become an important component of modern cancer treatment. The integration of advanced imaging systems, portable radiation delivery devices, AI-assisted treatment planning, and precision surgical techniques is further transforming the market landscape and creating significant opportunities for manufacturers and investors.

Review significant findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74059

Market Overview

Intraoperative radiation therapy represents a sophisticated cancer treatment process where the localized dose of radiation is administered to the tumor site during the operation. Oncologists can accurately target the cancerous tissues and avoid subjecting surrounding healthy organs and tissues to more radiation than necessary with this process.

The therapy is generally administered following tumor resection through surgery, in an effort to ensure that any remaining microscopic cancer cells are killed prior to surgical site closure. Localized delivery optimizes effectiveness of these treatment and minimizes repeated postoperative courses of radiotherapy, significantly lowering overall treatment time for patients.

IORT is generally associated with breast cancer, colon cancer, rectal cancer, pancreatic cancer, and gynaecological cancers, with that being a common feature among the diseases where accuracy and keeping the normal tissue intact are of utmost importance. When radiation is given intraoperatively, the practitioners can see and change the target area straight off, thus resulting in better dose precision and less side effects in comparison with the standard external beam radiation therapy.

Key Market Growth Drivers

Rising Global Cancer Burden

The increasing incidence of breast cancer, colorectal cancer, pancreatic cancer, brain tumors, and other solid tumors is significantly driving demand for advanced radiation therapy solutions.

Healthcare providers are adopting IORT to improve local tumor control while reducing treatment duration.

Growing Demand for Precision Oncology

The shift toward personalized and precision-based cancer treatment is accelerating the adoption of targeted radiation therapies.

IORT enables clinicians to deliver radiation directly to the affected area with greater accuracy and reduced damage to healthy tissues.

Technological Advancements in Radiation Therapy

Continuous innovation in portable radiation systems, imaging technologies, treatment planning software, and AI-assisted radiation delivery is improving the safety and effectiveness of IORT procedures.

Manufacturers are also developing compact and mobile systems for easier integration into operating rooms.

Increasing Adoption of Minimally Invasive Cancer Treatments

Healthcare providers are increasingly focusing on treatment approaches that reduce hospital stays, minimize complications, and improve patient recovery.

IORT supports comprehensive cancer treatment by combining surgery and radiation therapy in a single procedure.

Analysis of Key Players

The intraoperative radiation therapy market is highly competitive, with manufacturers focusing on technological innovation, clinical research, and strategic collaborations.

• ZEISS Group
• Elekta
• Varian (Siemens Healthineers)
• Sensus Healthcare, Inc.
• S.I.T. Sordina IORT Technologies S.p.A.
• Eckert & Ziegler
• Becton, Dickinson and Company
• Synektik
• iCAD, Inc.
• Accuray Incorporated
• PTW Freiburg GmbH
• SeeDOS Ltd
• Theragenics Corporation
• BEBIG Medical.
• CIVCO Medical Solutions

Key Developments in Intraoperative Radiation Therapy Market

·        In April 2025, The ZEISS INTRABEAM 700 platform received 510(k) clearance from the U.S. FDA in order to be utilized as a robot-assisted system to aid intraoperative radiation therapy in neuro-oncology and breast cancer surgery. The INTRABEAM 700 platform combined digital-first design with robot-assisted accuracy to maximize procedural efficacy and multidisciplinary integration.

·        In October 2024, Aster DM Healthcare had become the nation's first healthcare system to deliver Intra-Operative Electron Radiation Therapy (IOeRT), a revolutionary innovation in cancer treatment. The latest state-of-the-art medical centre was accessible at the Aster International Institute of Oncology (AIIO), Aster Whitefield Hospital, Bengaluru and is a giant leap in the hospital's mission to deliver the best quality treatment solutions to patients suffering from cancer.

Key Player Strategies

Leading companies are implementing several strategic initiatives to strengthen market competitiveness:

• Development of compact and mobile IORT systems
• Integration of AI-assisted treatment planning technologies
• Expansion of precision radiation oncology product portfolios
• Strategic collaborations with hospitals and cancer centers
• Investment in advanced imaging and dosimetry technologies
• Continuous clinical research to expand treatment indications
• Geographic expansion into emerging healthcare markets
• Enhancement of radiation safety and workflow automation
• Development of next-generation low-energy X-ray systems
• Strengthening training and technical support for healthcare providers

These strategies are helping companies strengthen their competitive position while supporting the growing adoption of precision cancer therapies.

Market Challenges & Opportunities

Challenges

Despite favorable growth prospects, the market faces challenges including high equipment costs, limited availability of specialized treatment centers, stringent regulatory approval requirements, and the need for multidisciplinary clinical expertise.

Healthcare providers must also address reimbursement limitations and the significant capital investment required for IORT infrastructure.

Opportunities

Growing investments in oncology care, increasing adoption of precision medicine, expansion of cancer treatment facilities, and technological advancements in radiation delivery systems present significant opportunities for market participants.

The integration of AI, image-guided surgery, robotic-assisted procedures, and personalized treatment planning is expected to create additional growth opportunities.

Increasing healthcare expenditure and improving access to advanced cancer care in emerging economies will further support long-term market expansion.

Investment Landscape and ROI Outlook

The Intraoperative Radiation Therapy Market continues to attract investments from medical device manufacturers, oncology technology companies, healthcare providers, research institutions, and private equity investors.

Investment is increasingly directed toward advanced radiation delivery systems, AI-enabled treatment planning platforms, portable IORT technologies, and clinical research initiatives.

As the global demand for precision oncology and advanced cancer treatment continues to rise, the market is expected to generate attractive long-term returns on investment through 2035.

The combination of increasing cancer prevalence, technological innovation, growing adoption of minimally invasive therapies, and expanding oncology infrastructure positions the intraoperative radiation therapy market as a promising growth segment within the global radiation oncology industry.

Market Segmentation

Technology

• Electron Intraoperative radiotherapy (IORT)
• High-Dose-Rate (HDR) Brachytherapy
• Others (Low-Kilovoltage (kV) X-ray IORT, etc.)

Products and Services

• Products
• Systems and Accelerators
• Applicators and Afterloaders
• Imaging / Navigation Integration Tools
• Accessories & Consumables
• Software
• Services

Indication

• Head & Neck Cancer
• Gastrointestinal Cancer
• Colorectal Cancer
• Lung Cancer
• Endometrial & Cervical Cancer
• Breast Cancer
• Penile & Prostate Cancer
• Others (Brain Tumor, etc.)

End-users

• Hospitals
• Oncology Clinics
• Ambulatory Surgical Centers
• Academic and Research Institutes

Why Buy This Report?

• Gain comprehensive insights into current and future intraoperative radiation therapy market trends
• Access detailed market size estimates and forecasts through 2035
• Understand key growth drivers, challenges, and emerging opportunities
• Evaluate competitive positioning of leading radiation oncology technology providers
• Analyze advancements in precision radiation therapy, AI-assisted treatment planning, and image-guided oncology
• Assess regional and segment-level market dynamics
• Identify high-growth investment opportunities across the oncology technology value chain
• Track recent product launches, partnerships, acquisitions, clinical developments, and technological innovations
• Support strategic business planning and investment decisions
• Obtain actionable market intelligence to strengthen competitive positioning

Buy this Premium Research Report to gain valuable industry intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=74059<ype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com